oral glutathione skin lightening evidence randomized controlled trial review Comparative Efficacy of Tranexamic Acid... : Medical Journal of Dr. D.Y. Patil Vidyapeeth Glutathione as a skin‐lightening agent

[n.s.], data not shown)

10.1172/jci.insight.85717 JCI Insight

(2013) selected and transplanted the resistant tumor clones into Severe Combined Immunodeficient (SCID) mice and resumed the Selumetinib treatment and showed that the resistance of BT-40 xenografts to Selumetinib was mediated by activation of STAT3 signaling, so STAT3 activation could be compensating for MEK inhibition to maintain proliferation and survival (50)

Restivo had to work with

Pharmaceutical prospects of Silymarin for the treatment of neurological patients: an updated insight

The endocrine implications of this phenomenon, however, were not sufficiently emphasized in the discussion